Nuformix plc (LON:NFX – Get Free Report)’s share price reached a new 52-week low during mid-day trading on Tuesday . The stock traded as low as GBX 0.18 ($0.00) and last traded at GBX 0.18 ($0.00), with a volume of 1347616 shares traded. The stock had previously closed at GBX 0.21 ($0.00).
Nuformix Stock Up 8.1 %
The firm’s 50-day moving average price is GBX 0.22 and its 200-day moving average price is GBX 0.27. The company has a market cap of £1.64 million, a price-to-earnings ratio of -1.63 and a beta of 0.29. The company has a debt-to-equity ratio of 1.17, a current ratio of 1.51 and a quick ratio of 3.35.
Nuformix Company Profile
Nuformix plc operates in the field of pharmaceutical development for treating fibrosis and oncology through drug repurposing in the United Kingdom. It offers NXP001, which has completed Phase 1 for use in oncology supportive care. The company is also developing NXP004, a novel form of Olaparib, which is in the IP generation phase for treating oncology; and NXP002 that is in pre-clinical stage for the treatment of idiopathic pulmonary fibrosis.
See Also
- Five stocks we like better than Nuformix
- Manufacturing Stocks Investing
- Hasbro’s Management Made All the Right Calls This Quarter
- Stock Market Upgrades: What Are They?
- Caterpillar’s Market Reset Isn’t Over: Get Ready for Lower Prices
- How to Choose Top Rated Stocks
- Power Surge: Utilities Sector’s Resilience Shines
Receive News & Ratings for Nuformix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nuformix and related companies with MarketBeat.com's FREE daily email newsletter.
